BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38465123)

  • 1. A Case Report of Primary Aldosteronism and Extensive Hypertension-Mediated Organ Damage.
    Brum de Sousa E; do Mar Menezes M; Cordeiro AM
    Cureus; 2024 Feb; 16(2):e53818. PubMed ID: 38465123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual presentation of primary aldosteronism with advanced target organ damage: A case report.
    Fava C; Cattazzo F; Bernasconi R; Romano S; Minuz P
    Radiol Case Rep; 2019 Jul; 14(7):814-818. PubMed ID: 31024637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.
    Shigematsu Y; Hamada M; Okayama H; Hara Y; Hayashi Y; Kodama K; Kohara K; Hiwada K
    Hypertension; 1997 Mar; 29(3):723-7. PubMed ID: 9052887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for primary aldosteronism is underutilised in patients with chronic kidney disease.
    Chauhan K; Schachna E; Libianto R; Ryan J; Hutton H; Fuller PJ; Wilson S; Kerr PG; Yang J
    J Nephrol; 2022 Jul; 35(6):1667-1677. PubMed ID: 35195879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea.
    Yoon M; Hong N; Ha J; Lee CJ; Ku CR; Rhee Y; Park S
    Hypertens Res; 2022 Sep; 45(9):1418-1429. PubMed ID: 35681044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
    Monticone S; D'Ascenzo F; Moretti C; Williams TA; Veglio F; Gaita F; Mulatero P
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):41-50. PubMed ID: 29129575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What We Know about and What Is New in Primary Aldosteronism.
    Ekman N; Grossman AB; Dworakowska D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases.
    Chen CT; Wang YC; Lin CM
    Am J Case Rep; 2021 Apr; 22():e929758. PubMed ID: 33838028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
    Chen LG; Lee TI; Lin HD; Wang HC; Liu WY; Tang KT
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Feb; 59(2):114-20. PubMed ID: 9175301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution features of hypertensive patients with primary aldosteronism--prospective study.
    Chioncel V; Păun D; Amuzescu B; Sinescu C
    J Med Life; 2012 Sep; 5(3):354-9. PubMed ID: 23049641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
    Miyamoto S; Yoshida Y; Ozeki Y; Okamoto M; Gotoh K; Masaki T; Nishida H; Fujinami H; Shin T; Daa T; Asayama Y; Shibata H
    BMC Endocr Disord; 2023 Feb; 23(1):44. PubMed ID: 36797699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing Investigations Establish the Challenging Diagnosis of Primary Aldosteronism.
    Aung T; Tulsidas H
    Cureus; 2021 Nov; 13(11):e19613. PubMed ID: 34926077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.